176 related articles for article (PubMed ID: 32112307)
1. Application of the Z1071 criteria: classification of axillary lymph nodes on ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer.
Iwamoto N; Miyamoto H; Horiguchi S; Honda Y; Aruga T
J Med Ultrason (2001); 2020 Apr; 47(2):299-303. PubMed ID: 32112307
[TBL] [Abstract][Full Text] [Related]
2. Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).
Boughey JC; Ballman KV; Hunt KK; McCall LM; Mittendorf EA; Ahrendt GM; Wilke LG; Le-Petross HT
J Clin Oncol; 2015 Oct; 33(30):3386-93. PubMed ID: 25646192
[TBL] [Abstract][Full Text] [Related]
3. Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).
Le-Petross HT; McCall LM; Hunt KK; Mittendorf EA; Ahrendt GM; Wilke LG; Ballman KV; Boughey JC
AJR Am J Roentgenol; 2018 Mar; 210(3):669-676. PubMed ID: 29381381
[TBL] [Abstract][Full Text] [Related]
4. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
[TBL] [Abstract][Full Text] [Related]
5. Application of ACOSOG Z1071: Effect of Results on Patient Care and Surgical Decision-Making.
Palmer JAV; Flippo-Morton T; Walsh KK; Gusic LH; Sarantou T; Robinson MM; White RL
Clin Breast Cancer; 2018 Aug; 18(4):270-275. PubMed ID: 29129549
[TBL] [Abstract][Full Text] [Related]
6. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
[TBL] [Abstract][Full Text] [Related]
7. Axillary Nodal Burden Assessed with Pretreatment Breast MRI Is Associated with Failed Sentinel Lymph Node Identification after Neoadjuvant Chemotherapy for Breast Cancer.
Kim WH; Kim HJ; Park CS; Lee J; Park HY; Jung JH; Kim WW; Chae YS; Lee SJ; Kim SH
Radiology; 2020 May; 295(2):275-282. PubMed ID: 32125253
[TBL] [Abstract][Full Text] [Related]
8. Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands.
Vugts G; Maaskant-Braat AJ; de Roos WK; Voogd AC; Nieuwenhuijzen GA
Eur J Surg Oncol; 2016 Jul; 42(7):956-64. PubMed ID: 27107791
[TBL] [Abstract][Full Text] [Related]
9. The Relevance of Ultrasound Imaging of Suspicious Axillary Lymph Nodes and Fine-needle Aspiration Biopsy in the Post-ACOSOG Z11 Era in Early Breast Cancer.
Vijayaraghavan GR; Vedantham S; Kataoka M; DeBenedectis C; Quinlan RM
Acad Radiol; 2017 Mar; 24(3):308-315. PubMed ID: 27916595
[TBL] [Abstract][Full Text] [Related]
10. CT-Guided Wire Localization for Involved Axillary Lymph Nodes After Neo-adjuvant Chemotherapy in Patients With Initially Node-Positive Breast Cancer.
Trinh L; Miyake KK; Dirbas FM; Kothary N; Horst KC; Lipson JA; Carpenter C; Thompson AC; Ikeda DM
Breast J; 2016 Jul; 22(4):390-6. PubMed ID: 27061012
[TBL] [Abstract][Full Text] [Related]
11. Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature.
Banys-Paluchowski M; Gruber IV; Hartkopf A; Paluchowski P; Krawczyk N; Marx M; Brucker S; Hahn M
Arch Gynecol Obstet; 2020 Feb; 301(2):341-353. PubMed ID: 31897672
[TBL] [Abstract][Full Text] [Related]
12. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
Kang YJ; Han W; Park S; You JY; Yi HW; Park S; Nam S; Kim JH; Yun KW; Kim HJ; Ahn SH; Park S; Lee JE; Lee ES; Noh DY; Lee JW
Breast Cancer Res Treat; 2017 Nov; 166(2):473-480. PubMed ID: 28766131
[TBL] [Abstract][Full Text] [Related]
13. The impact of axillary ultrasound with biopsy in overtreatment of early breast cancer.
Del Riego J; Diaz-Ruiz MJ; Teixidó M; Ribé J; Vilagran M; Canales L; Sentís M;
Eur J Radiol; 2018 Jan; 98():158-164. PubMed ID: 29279156
[TBL] [Abstract][Full Text] [Related]
14. The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT).
Peppe A; Wilson R; Pope R; Downey K; Rusby J
Breast; 2017 Oct; 35():104-108. PubMed ID: 28704697
[TBL] [Abstract][Full Text] [Related]
15. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
[TBL] [Abstract][Full Text] [Related]
16. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
17. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.
Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF
Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of breast ultrasonography and MRI in the prediction of lymph node status after neoadjuvant chemotherapy for breast cancer.
Ha SM; Cha JH; Kim HH; Shin HJ; Chae EY; Choi WJ
Acta Radiol; 2017 Oct; 58(10):1198-1205. PubMed ID: 28350255
[TBL] [Abstract][Full Text] [Related]
19. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.
Zheng Q; Yan H; He Y; Wang J; Zhang N; Huo L; Liu Y; Wang L; Xu L; Fan Z
Cancer; 2024 Apr; 130(S8):1513-1523. PubMed ID: 38427584
[TBL] [Abstract][Full Text] [Related]
20. A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study.
van Nijnatten TJA; Simons JM; Smidt ML; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef K; Koppert LB; Luiten EJT
Clin Breast Cancer; 2017 Aug; 17(5):399-402. PubMed ID: 28487053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]